There have also been several reports of specific low-occurrence mutations in RPL5 and RPL10 and overexpression of RPS9 in MM that were closely related to tumorigenesis and clinical outcomes (Dabbah et al., 2021). Here, RPL5 is linked to Miyoshi myopathy.